Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate vs Tofacitinib in Chronic Plaque Psoriasis
NCT07581418Not yet recruiting
- Sponsor
- Pak Emirates Military Hospital
- Start
- Jun 2026
- Primary completion
- Dec 2026
- Modality
- Small Molecules
01
Overview
Randomised trial of tofacitinib oral solution in psoriasis (2 arms), sponsored by Pak Emirates Military Hospital. Primary endpoint: Psoriasis Area and Severity Index at 8 weeks. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
tofacitinib oral solution
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT07581418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07581418.